Press Release

Reemo Health Enters Into Know-How Agreement With Mayo Clinic For TechEnabled Cardiac Rehab And Maintenance

Home-based cardiac management programs will deliver personalized care plans and dynamic
support to people with cardiovascular disease through Reemo’s intuitive smartwatch experience

Minneapolis, MN (October 19, 2021) – Reemo Health, a connected health company specializing in
home-based health management, today announced a know-how agreement with Mayo Clinic. This
agreement will incorporate Mayo Clinic’s expert clinical content, care pathways and clinical validation
to Reemo’s smartwatch-enabled cardiovascular programs. These home-based cardiac rehab and
long-term cardiac maintenance programs are designed to improve patient enrollment, engagement
and satisfaction as compared to traditional condition management offerings.

“Only 25% of eligible patients typically enroll in conventional cardiac rehab, so there is a clear need
for a new, consumer-friendly approach to this critical program,” said John Valiton, chief executive
officer of Reemo Health. “It is an honor to collaborate with Mayo Clinic and combine their deep
clinical expertise with Reemo’s proficiency in achieving program adoption and adherence by highrisk,
high-complexity users.”

Home-based cardiovascular programs increase the access to rural and transportation-dependent
patients by reducing the need for in-person clinic visits and represent the latest advancement in
Reemo’s wearable health platform. Through passive and active interactions and underlying learned
intelligence, the Reemo platform generates longitudinal clinical, health and lifestyle insights for an
actionable and dynamic risk profile of cardiac patients that enables successful home-based cardiac

About Reemo Health
Reemo Health transforms how people connect to their health and their care. Its wearable-enabled
health management platform incorporates user-friendly 1:1 messaging, remote monitoring, digital
care plans and condition management experiences to successfully engage and manage high-risk
populations in the comfort of their own homes and beyond. Reemo’s technology is used by leading
health plans, value-based providers and life science organizations to deliver better connected health
to their consumers. Reemo is proudly headquartered in Minneapolis, Minn., in the heart of Medical
Alley. For more information, visit


Andy Gonerka, Chief Growth Officer
Reemo Health

CTA Launches New Trustworthiness Standard for AI in Health Care

by Riya Anandwala

More than 60 organizations – from global tech brands to startups and health care industry leaders – convened by the Consumer Technology Association (CTA)® have developed a new ANSI-accredited standard that identifies the core requirements and baseline to determine trustworthy AI solutions in health care. This standard, part of CTA’s initiative on AI in health care, is the second in a series of standards focused on implementing medical and health care solutions built on AI.

“AI is providing solutions – from diagnosing diseases to advanced remote care options – for some of health care’s most pressing challenges,” said Gary Shapiro, president and CEO, CTA. “As the U.S. health care system faces clinician shortages, chronic conditions and a deadly pandemic, it’s critical patients and health care professionals trust how these tools are developed and their intended uses.”

The consensus-driven standard – ANSI/CTA-2090, The Use of Artificial Intelligence in Health Care: Trustworthiness – considers three expressions of how trust is created and maintained:

  • Human Trust focuses on fostering humanistic factors that affect the creation and maintenance of trust between the developer and users. Specifically, human trust is built upon human interaction, the ability to easily explain, user experience and levels of autonomy of the AI solution.
  • Technical Trust focuses on the technical execution of the design and training of an AI system to deliver results as expected. Technical trust can also be defined by considerations for data quality and integrity including issues of bias, data security, privacy, source and access.
  • Regulatory Trust is gained through compliance by industry based upon clear laws and regulations. This trust can be based upon information from regulatory agencies, federal and state laws and accreditation boards and international standardization frameworks.

“Establishing these pillars of trust represents a step forward in the use of AI in health care,” said Pat Baird, regulatory head of global software standards at Philips and co-chair of the working group. “AI can help caregivers spend less time with computers, and more time with patients. In order to get there, we realized that different approaches are needed to gain the trust of different populations and AI-enabled solutions need to benefit our customers, patients and society as a whole. Collaboration across the health care ecosystem is essential to establish trust.”

Membership in the CTA Artificial Intelligence in Health Care working group has doubled in less than two years and includes a wide range of decision makers from 64 organizations and member companies. The new standard joins a previous standard outlining definitions and characteristics to provide a framework to better understand AI technologies and common terminology so consumers, tech companies and care providers can better communicate, develop and use AI-based health care technologies.

Participating organizations include:
98point6 Inc.
Activbody Inc.
Amalgam Rx
America’s Health Insurance Plans
BAND Connect
Bohua UHD
CarePredict, Inc.
Connected Health Initiative
Duke Margolis Center for Health Policy
Federation of State Medical Boards
GlucosoneZone by Fitscript
GR Schulz Associates
Humanity Innovation Labs
Jones Day
Lumos Health
Matrix Advisors, LLC
MindMaze S.A.
Osso VR
SHIFT Performance Global
The Joint Commission
The Omega Concern
United Spinal Association
Valencell, Inc.

To view the standard, visit

Reemo Health Receives Provider Approval – Giving More Users Access to Personal Independence Smartwatch

Milestone reinforces company’s mission to develop and deliver approachable technology that remotely supports the health and safety of aging and at-risk seniors in their homes


Minneapolis, MN (September 22, 2020) – Reemo Health, simplifying how consumers and healthcare connect remotely, is now an approved Personal Emergency Response System (PERS) Provider for Home & Community-Based Services (HCBS) Waiver Programs in the State of Minnesota. Minnesota is the first state in the company’s rollout strategy for creating widespread availability to HCBS-eligible seniors.


“The availability of Reemo’s PERS smartwatch through HCBS Waiver Programs expands the positive impact the company can provide to consumers as they manage health risks, COVID-vulnerability and disruption of traditional care pathways,” said Andy Gonerka, Chief Growth Officer of Reemo Health. “As a company, we will continue to find more ways to give Americans access to this life saving device and clientele a technology platform that delivers critical health insights so more efficient and effective care and support can be realized.”


Reimagining the traditional PERS device, Reemo’s non-stigmatizing PERS smartwatch is easy to use and stylish. The LTE-connected smartwatch works wherever the consumer goes and provides additional benefits that other PERS devices lack including live call-for-help, 1:1 concierge support, step and heart rate tracking and GPS location. More so, Reemo helps the user connect with their personal care circle via shareable insights for friends, family and caregivers.

In addition to the provider approval news, Reemo is pleased to announce that preeminent technologist and health care executive Bud Flagstad will join its Board of Directors. Both announcements by the company demonstrate true leadership and advocacy in the industry and fulfill its mission of helping at-risk people and the young-at-heart remain independent and stay in their homes.


Mr. Flagstad brings expertise in driving consumer and provider engagement to increase access to high-quality care, enhancing efficiency and efficacy, and empowering people to improve their health and wellness to the Reemo Health Board of Directors. He has held executive leadership roles across the health insurance, private equity, medical startup and financial services industries during his prominent career.


“Bud Flagstad has a long and distinguished history of being on the forefront of nurturing new technology and approaches to disrupt the health care status quo,” said John Valiton, Chief Executive Officer of Reemo Health. “Even more importantly, Mr. Flagstad’s experience engaging all stakeholders involved in the health and care of an individual will provide Reemo with invaluable guidance as we advance how our Healthy Aging Platform can help improve well-being, lower health risks and reduce avoidable and costly healthcare claims.”


“It’s an honor to help the company advance aging-in-place and remote care initiatives,” Mr. Flagstad notes. “Reemo Health is uniquely positioned to help Americans from all walks of life in their daily lives along with the payers and providers that offer vital care.”


HCBS case managers, delegate organizations and MCOs in Minnesota can go to to receive more information on the Reemo PERS smartwatch, the enrollment process or request more information.




About Reemo Health

Reemo simplifies how consumers and healthcare remotely connect. We provide a personalized connected health platform for the predictive care and remote management of aging and rising-risk populations. Our wearable-first experience turns in-home consumer access and remotely collected data into targeted actions that mitigate costs and maximize payments for high-risk, high-cost populations. Reemo delivers a better way for consumers to engage in their health and a better way for healthcare to apply data so people can stay healthy at home. For more information visit or contact us at

CTA Launches First-Ever Industry-Led Standard for AI in Health Care

More than 50 organizations – from major tech giants to startups and health care industry leaders – convened by the Consumer Technology Association (CTA)® have developed the first-ever ANSI-accredited standard for the use of artificial intelligence in health care. This standard, part of CTA’s new initiative on AI, is the first in a series that will set a foundation for implementing medical and health care solutions built on AI.

“This standard creates a firm base for the growing use of AI in our health care—technology that will better diagnose diseases, monitor patients’ recoveries and help us all live healthier lives,” said Gary Shapiro, president and CEO, CTA. “This is a major first step – convening some of the biggest players in the digital health world – to help create a more efficient health care system and offer value-based health care to Americans.”

AI-related terms are used in different ways, leading to confusion – especially in the health care industry, including telehealth and remote patient monitoring. To address this problem, CTA announced the working group with 30 members less than a year ago, which now includes a wide range of decision makers from 52 organizations and member companies to develop a standard built on consensus. The standard – 11 definitions and characteristics – provides a framework for better understanding AI technologies and common terminology so consumers, tech companies and care providers can better communicate, develop and use AI-based health care technologies.

A broader AI committee at CTA also published an ANSI-accredited standard that addresses the pervasiveness of AI-enabled technology across the entire consumer technology industry. The standard defines over 30 terms including machine learning, model bias, artificial neural network and trustworthiness.

“So far, common terminology has defined the intent of use — and that’s one of the most significant challenges in developing standard application of AI,” said Rene Quashie, VP, policy and regulatory affairs, digital health, CTA. “As health systems and providers use AI tools such as machine learning to diagnose, treat and manage disease, there’s an urgent need to understand and agree on AI concepts for consistent use. This standard does exactly that.” As the healthcare system deals with clinician shortages, an aging population and the persistence of chronic diseases in the US, technologically driven solutions, such as AI, will increasingly be used to meet clinician and patient needs, the group notes.

Among the definitions, the standard includes highly debated terms such as “assistive intelligence,” which the group defined as a category of AI software that “informs” or “drives” diagnosis or clinical management of a patient, however the health care provider makes the ultimate decisions before clinical action is taken.

“AI will play a major role in driving efficiency in healthcare and will support clinicians in making more precise diagnosis, offer personalized treatment and better guidance towards improved outcomes,” said Pat Baird, regulatory head of global software standards at Philips and co-chair of the working group. “This implies that AI will be used for decision support and decision making, which stresses the need for professionals to be able to take ownership, apply judgment and empathy. Transparency and a common language will be key to enable the proper and safe functioning of AI.”

Other definitions include terms like de-identified data, synthetic data, remote patient monitoring and patient decision support system.

Participating organizations include:

98point6 Inc.
American Association for Clinical Chemistry
American Medical Association
American Telemedicine Association
Aural Analytics
Brookings Institution
CarePredict, Inc.
Connected Health Initiative
Doctor on Demand
Duke-Robert J. Margolis, MD, Center for Health Policy
Federation of State Medical Boards
Google Inc.
Health Innovational Alliance
Intel Corporation
LG Electronics
Livongo Health
Magic Leap, Inc.
Matrix Advisors, LLC
Mercedes Benz – A Daimler Brand
Microsoft Corporation
MindMaze S.A.
National Urban League Washington Bureau
Osso VR
SDI Technologies, Inc.
SHIFT Performance Global
The Joint Commission
The Omega Concern, LLC
United Spinal Association
Volar Health, LLC
VOXX International

Consumer Technology Association:
As North America’s largest technology trade association, CTA® is the tech sector. Our members are the world’s leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES® – the largest, most influential tech event on the planet. Find us at Follow us @CTAtech.